Pharmaceutical Recent years have shown encouraging signs of progress in the development of treatments for Alzheimer's as pharma and academia begin to better comprehend the causes. Thanks to new findings, effective treatments could now be within reach. Alzheimer's and dementia researchers gathered in Toronto, Canada, last week for the Alzheimer's Association International Conference (AAIC) 2016, where interesting developments were showcased. Joel Levy reports. 1 August 2016